Pharmaceuticals

MODERN CHI MED

Modern Chinese Medicine Group Responds to High Shareholder Concentration Inquiry

Modern Herbal Group Responds to HKEX Shareholder Concentration Inquiry

MODERN CHI MED released FY2025 Q3 earnings on March 30, 2026 (BJT), with actual revenue of HKD 43.95 M and EPS of HKD -0.0121

MODERN CHI MED released FY2025 9 Months Earnings on March 30, 2026 (BJT), actual revenue HKD 114.07 M, actual EPS HKD -0.0076

Modern Herbal Medicine Group reports a net loss of 14 million yuan in the fiscal year 2025

MODERN CHI MED released FY2025 Q4 earnings on March 30 After-Market (BJT), actual revenue HKD 44.71 M, actual EPS HKD -0.0123

MODERN CHI MED released FY2025 Annual Earnings on March 30 After-Market BJT, actual revenue HKD 158.67 M, actual EPS HKD -0.0224

MODERN CHI MED to Release FY2025 Earnings on March 30 After-Market (BJT)

MODERN CHI MED released FY2025 Q1 earnings on August 29, 2025 (BJT) with actual revenue of HKD 34.68 M and EPS of HKD 0.0021

MODERN CHI MED released FY2025 Semi-Annual Earnings on August 29 After-Market BJT, actual revenue HKD 70.12 M, actual EPS HKD 0.0044

MODERN CHI MED released FY2025 Q2 earnings on August 29 After-Market BJT, actual revenue HKD 35.44 M, actual EPS HKD 0.0022

MODERN CHI MED to Release FY2025 Semi-Annual Earnings on August 29, 2025 (BJT)

Universal Health 增持 Modern Chinese Medicine Group 120 million shares

Modern Herbal Group Issues 120 Million Subscription Shares

Investment of 32.4 million yuan in new business opportunities related to traditional Chinese medicine and enhancement of R&D capabilities

Modern Chinese Medicine Group Signs Subscription Agreement with Global Health Investment Fund to Issue 120 Million Shares

MODERN CHI MED released FY2024 Q3 earnings on March 26 (BJT) with actual revenue of 76.17 M HKD and EPS of 0.0152 HKD

MODERN CHI MED released FY2024 9 Months Earnings on March 26 (BJT), with actual revenue of 158.86 M HKD and EPS of 0.0029 HKD

Modern Chi Med released FY2024 Q4 earnings on March 26 After-Market (BJT), actual revenue 73.11 M HKD, actual EPS 0.0146 HKD

MODERN CHI MED released FY2024 annual earnings on March 26 After-Market (BJT), actual revenue 231.72 M HKD, actual EPS 0.0174 HKD

HINSANG GROUP

RIVERINE CHINA

PASHUN INT RTS

BRAINAURORA-B

SOFTMEDX

GOLDENPOWER

ZHONGKE GROUP

VISION SYNERGY

GEMILANG INTL

GHPC

01643

Modern Chinese Medicine Group Co. Ltd. has received a waiver from the Hong Kong Stock Exchange, allowing a delay in sending a shareholder circular regarding its major acquisition. The circular is now expected to be sent by June 30, 2026, as the company needs more time to finalize key financial information. This waiver reduces immediate compliance pressure but introduces regulatory uncertainty for stakeholders. The company operates in modern Chinese medicine and is listed in Hong Kong with a market cap of HK$2.15B.

Tip Ranks

Modern Chinese Medicine Group Wins Waiver for Delay in Acquisition Circular

Modern Chinese Medicine Group Co. Ltd. has announced a delay in sending a shareholder circular regarding a major transaction, now expected by 30 June 2026 instead of 30 April 2026. The delay is due to the need for additional time to finalize financial information. The company has applied for a waiver from the Hong Kong Stock Exchange regarding the timing of the circular dispatch. Further announcements will follow as the company engages with regulators.

Modern Chinese Medicine Group Seeks More Time for Major Transaction Circular

Modern Chinese Medicine Group Co. Ltd. (HK:1643) plans to modernize its articles of association to align with updated Hong Kong Listing Rules and Cayman Islands law. The amendments will facilitate electronic communications, hybrid meetings, and electronic handling of corporate actions, pending shareholder approval at the upcoming AGM. This initiative aims to enhance corporate governance, operational efficiency, and shareholder engagement. The company, listed in Hong Kong and incorporated in the Cayman Islands, operates in the pharmaceutical and traditional Chinese medicine sector, with a market cap of HK$1.76B.

Modern Chinese Medicine Group to Modernise Articles of Association with Digital and Governance Upgrades

Modern Chinese Medicine Group Co. Ltd. (HK:1643) has announced a high concentration of shareholding, revealing key shareholders. Modern Biotechnology Group Holdings, owned by chairlady Sun Xinlei, holds 55.8% of shares, while Universal Health (Global) Investment Fund Management, owned by Chen Xiaoyan, holds 16.7%. This concentrated ownership structure indicates limited free float and potential liquidity issues for minority investors. The company, listed in Hong Kong, focuses on modernized traditional Chinese medicine products and has a market cap of HK$1.86B.

Modern Chinese Medicine Details Highly Concentrated Insider Shareholding

159316

513120

520880

520690

513700

Modern Chinese Medicine Group Co. Ltd. (HK:1643) announced a high concentration of shareholding, with 25 shareholders holding 90.6% of issued shares as of March 30, 2026. This raises concerns about market depth and trading dynamics. The company's share price surged 316% from HK$0.51 at the end of 2025 to HK$2.12 by March 30, 2026, and further to HK$2.94 by April 13, 2026. While the board meets the public float requirement, it warns of potential price volatility due to the concentrated shareholding, advising investors to exercise caution.

E Fund Hang Seng SCHK Innovative Drug ETF

GF CSI HK Innovative Drugs Industry ETF(QDII)

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

Bosera Hang Seng SCHK Innovative Drug Select ETF

Penghua CSI HK Connect Health Care Composite ETF

Modern Chinese Medicine Flags High Shareholding Concentration After Sharp Price Surge

06063

00723

01024

03858

09663

09992

02706

00797

The market overview of Hong Kong stocks in the past hour shows significant fluctuations in market sentiment, with a strong divergence in capital flows. The pharmaceutical sector's MODERN CHI MED performed outstandingly, with an increase of 22.95%, attracting a lot of short-term capital attention. In contrast, technology stocks appeared relatively weak, with KUAISHOU-W and JIAXIN INTL RES falling by 13.63% and 13.09%, respectively, indicating a cautious attitude towards tech stocks in the market. Overall, short-term enthusiasm is rapidly switching between different sectors, with increased volatility, and investor sentiment seems to be continuously adjusting. 

The strongest stock in the past hour, MODERN CHI MED's robust rise has drawn widespread attention from the market, with capital quickly pouring in, driving the stock price up significantly. The performance of this stock seems to have boosted the overall activity in the pharmaceutical sector, attracting the attention of many investors. 

Strong stocks:
1. MODERN CHI MED: up 22.95%, with significant capital inflow and high short-term sentiment.
2. SINOSYNERGY: up 12.91%, performing outstandingly in the new energy sector, attracting considerable investor attention.
3. JIAXIN INTL RES: despite the decline, there is still capital attempting to bottom-fish in the short term, showing some activity.

Stocks under pressure:
1. LOTUS HORIZON: down 20.16%, with market sentiment low and continued capital outflow.
2. RELIANCE GLO HL: down 15.00%, with significant short-term capital outflow and insufficient investor confidence.
3. KUAISHOU-W: down 13.63%, with increasing market concerns about tech stocks leading to pressure on the stock price

- Market sentiment in Hong Kong stocks showed significant volatility, with divergent capital flows across sectors.  
- The Modern Chinese Medicine Group surged by 22.95%, attracting considerable short-term investments, while tech stocks like Kuaishou and Jiahua International Resources dropped 13.63% and 13.09%, indicating caution in technology.  
- Overall, the investing mood appears to be rapidly shifting between various sectors, with an increased amplitude of fluctuations as short-term traders react.

HK Stock Alerts

LOTUS HORIZON

RELIANCE GLO HL

KUAISHOU-W

JIAXIN INTL RES

SINOSYNERGY

POP MART

HAIZHI TECH GP

7ROAD

Hong Kong Stock Movement Quick Report: MODERN CHI MED surged 22.95%, LOTUS HORIZON plummeted 20.16%, attracting attention

08340

03986

00899

00851

08299

08115

In the past hour, the Hong Kong stock market has shown a clear divergence, with some individual stocks performing actively, particularly in the technology and pharmaceutical sectors, attracting considerable attention from funds. GIGADEVICE and MODERN CHI MED, which have seen significant gains, seem to have drawn investors' eyes under the influence of short-term enthusiasm, resulting in strong buying pressure. Conversely, stocks under pressure such as ZIJING INTL FIN and SHENG YUAN HLDG have shown signs of capital outflow, reflecting a slightly cautious market sentiment. Overall volatility has been large, with increased activity from short-term traders and a faster market pace. The most volatile stock in the past hour, ZIJING INTL FIN, was once favored in the morning session but quickly fell back, with a decline of 16.92%. This fluctuation has attracted market attention, as short-term funds seem to have doubts about its prospects, leading to accelerated selling. 

Strong stocks:
1. GIGADEVICE: Up 15.88%, with significant capital inflow driven by technology stocks and heightened short-term sentiment.
2. MODERN CHI MED: Up 15.31%, benefiting from the enthusiasm in the pharmaceutical sector, with the market full of expectations for its future development.
3. ZHONG JIA GX: Up 15.00%, recently active and attracting considerable attention from short-term funds.
4. SHANGHAI QINGPU: Up 10.74%, performing outstandingly in the safety-related sector, with optimistic market sentiment.

Stocks under pressure:
1. SHENG YUAN HLDG: Down 11.25%, with poor market expectations for its future performance and significant capital outflow.
2. GT GOLD: Down 10.77%, with investor sentiment becoming cautious against the backdrop of fluctuating metal prices

ZIJING INTL FIN

GIGADEVICE

ZHONG JIA GX

SHENG YUAN HLDG

GT GOLD

QINGDA ORIENTAL

Hong Kong Stock Market Movement Update: Market Movement: ZIJING INTL FIN plummets 16.92%, GIGADEVICE rises 15.88% leading the rebound

09618

09988

09896

On February 10th, the Hong Kong stock market's three major indices collectively closed higher, with the Hang Seng Technology Index leading the way with a 0.84% increase. On the market, the surge in AI applications and the rebound of Chinese concept stocks drove the retail sector up, with Alibaba rising 1.46% and JD.com increasing 2.32%. The restaurant sector weakened due to the drag from heavyweight stocks, with Meituan falling 3.02% and HAIDILAO dropping 3.0%. In terms of capital, the market is in a macro data vacuum period, focusing on liquidity games. In individual stocks, POP MART performed strongly with a 4.35% increase, while Tencent Holdings had the highest trading volume but slightly fell by 1.07%

- On February 10, Hong Kong stocks showed a collective increase, with the Hang Seng Index closing at 27,172.87 points, up 0.54%.  
- The tech sector led the gains, with the Hang Seng Tech Index rising 0.84%, while the retail sector benefited from optimism surrounding AI applications.  
- Several individual stocks experienced notable movements, such as Global Printing Holdings surging 59.18% and Meituan dropping 3.02%, reflecting varied investor sentiment across sectors.

Market Pulse

JD-SW

BABA-W

MNSO

BIDU-SW

MEITUAN

HAIDILAO

YUM CHINA

UNI PRINTSHOP

CHINA WACAN

WANKA ONLINE

BAO PHARMA-B

Hang Seng Index

Hang Seng Composite Index

CAM HS TECH

Hang Seng TECH Index

GX HS TECH

BABA 2x Long Daily ETF - GraniteShares

KraneShares 2x Long BABA Daily ETF

Tianhong Hang Seng TECH ETF(QDII)

FI CSOP HSI

Krne Csi China Internet

FL2 CSOP HSI

Huatai-PB CSOP Hang Seng Technology ETF(QDII)

Alibaba

CSOP HS TECH

TENCENT

FI2 CSOP HSI

Hong Kong Stock Midday Review | Hang Seng Tech Index rises 0.84%, AI logic helps Alibaba rise 1.46%, weight drags Meituan down 3.02%

01347

00HSI

00700

On February 2nd, Hong Kong stocks closed lower across the board, with all three major indices declining and the technology sector under pressure. The top ten stocks by trading volume all closed in the green, reflecting short-term profit-taking pressure in the market. The pace of economic recovery and macro data have become the focus of attention, with an increase in cautious sentiment among investors

- On February 2, Hong Kong stocks fell, with the Hang Seng Index closing at 26,775.57, down 2.23%.  
- The consumer and retail sectors faced declines due to weak demand, while the gold sector saw significant outflows amid price volatility; top companies like Tencent and Alibaba experienced notable drops in share prices.  
- Investors are closely monitoring macroeconomic indicators such as foreign exchange reserves and unemployment rates, which are expected to significantly impact the market's future performance.

HUA HONG SEMI

ZIJIN MINING

ZIJIN GOLD INTL

SD GOLD

MINIMAX-W

ART GROUP HOLD

BASETROPHY GP

MOBVOI

SMIC

CHINA MOBILE

BYD COMPANY

Hong Kong stocks close | Hang Seng Index falls 2.23%, technology sector under significant pressure, precious metals plummet

MODERN CHI MED(01643.HK)